Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone Propionate Inhalation Powder vs Flovent Diskus in Adult Asthma
CTR20222304Phase 3Completed
- Sponsor
- Runsheng Pharmaceutical
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of fluticasone propionate in asthma (2 arms), sponsored by Runsheng Pharmaceutical. Primary endpoint: Change in pre-dose FEV1 from baseline at week 4. Started Sep 2022; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20222304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222304.